-
Gestalt Diagnostics and Mindpeak provide the first Artificial Intelligence based diagnostics solution used in clinical routine pathology in the USA
Hamburg, Germany, based Mindpeak and Spokane, WA, based Gestalt Diagnostics have achieved a major success on their way to improve patient care with Digital Pathology and Artificial Intelligence (AI). US based BioReference Laboratories, Inc., an OPKO Health company and one of the largest laboratories in the United States with 19 million patients per year, is now using Gestalt Diagnostic’s Digital Pathology Solution with Mindpeak’s AI-based cancer diagnostics BreastIHC algorithm in routine practice. The algorithm is being used for the quantification of breast cancer cells. The AI software is integrated into Gestalt Diagnostics’s PathFlow platform for streamlined access and workflow for BioReference’s pathologists and external pathology customers. This makes BreastIHC the…
-
Mindpeak announces CE-mark for UI interface „AI Console“ for optimal display of AI results of its cancer diagnostic software
Mindpeak, a Global leader in Artificial Intelligence in pathology, today announced that its new product "AI Console" has received the CE-Mark. The "AI Console" viewer enables optimal on-screen display of analysis results from Mindpeak’s AI-assisted cancer diagnostic tools, such as the CE-marked BreastIHC. "With our new AI Console, we offer experts – especially pathologists – an optimised display of our AI results. For example, the data and information that is crucial for the pathologist – such as the distinction between tumorous cells and non-tumorous cells – is highlighted in the user interface," explains Mindpeaks CEO Felix Faber. The user interface works quickly, is very responsive and enables a particularly well…
-
Das Potenzial des maschinellen Lernens bei der Digitalisierung der Pathologie
Mindpeaks CTO Dr. Tobias Lang und Dr. med. Holger Hauspurg vom Institut für Hämatopathologie Hamburg beschreiben die Zukunft der Krebsdiagnostik in einem Beitrag für die Zeitschrift Journal Onkologie. Die Krebsdiagnostik steht vor immensen Herausforderungen. Vor dem Hintergrund der weltweit stark steigenden Zahl von Krebserkrankungen muss die Pathologie bei gleichbleibenden oder sogar sinkenden Kapazitäten immer mehr Diagnosen erstellen. Die Digitalisierung der Krebsdiagnostik spielt dabei eine entscheidende Rolle. Die enorme Bedeutung von maschinellem Lernen und Deep Learning für die Digitalisierung der Pathologie und damit die Verbesserung der Krebsdiagnostik beschreiben der Gründer und CTO von Mindpeak Dr. Tobias Lang und Dr. Holger Hauspurg vom Institut für Hämatopathologie Hamburg in einem Beitrag für die…
-
The potential of machine learning in the digitalisation of pathology
Mindpeak’s CTO Dr. Tobias Lang and Dr. med. Holger Hauspurg from the Institut for Hematopathology Hamburg describe the future of cancer diagnostics in an article for the magazine Journal Oncology. Cancer diagnostics is facing immense challenges. Against the backdrop of the sharp rise in the number of cancer cases worldwide, pathology must produce more and more diagnoses while capacities remain the same or even decrease. The digitalisation of cancer diagnostics plays a decisive role in this issue. The enormous importance of machine learning and deep learning for the digitisation of pathology and thus the improvement of cancer diagnostics is described by the founder and CTO of Mindpeak Dr. Tobias Lang…
